Infectious Diseases in Adults 2026
- Continuing Education
Infectious Diseases in Adults 2026 provides state-of-the-art approaches for the prevention, diagnosis, and management of infectious diseases: common, challenging, rare, and emerging.
- Live Online
This program uses state-of-the-art streaming technology to present sessions online in real time. Participants can attend from any location, and can interact with faculty via live chat and interactive meet-the-professor sessions.
Additionally, all sessions will be recorded and made available to participants for online viewing for 90 days after the end of the course.
All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 30 days in order to receive CME credit.)
$1,275 Save with early registration
Save $100. The tuition listed above is for most health professionals; see the course fee table for pricing for residents and fellows. To ensure your participation at the lowest possible cost, early registration is strongly recommended.
Fee increases to $1,375 after
Continuing Education
Earn up to:
» 45.25 AMA PRA Category 1 Credits™
» 45.25 ABIM MOC points
» 45.25 Live AAFP Prescribed credits
» 45.25 ACPE CPE credit hours
» 45.25 ECME Credits®
» 9.25 credits of Risk Management Study, including 6.25 credits of Opioid Education and Pain Management Training
» Commensurate credits through the Royal College of Physicians and Surgeons of Canada
5 Days
This intensive course, which is among the highest-rated Harvard Medical School CME courses, presents the most up-to-date, evidence-based approaches to infectious diseases.
On This Page
Overview
State-of-the-Art Approaches to Prevention, Diagnosis, and Treatment of Infectious Diseases in Adults
Infectious Diseases in Adults 2026 is LIVE STREAMED with on-demand access available for 90 days after the course.
This comprehensive CME program, now in its 50th year, ensures attendees are current with state-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases. Updates, best practices, and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results-driven:
- Optimal decision-making across a range of common and unusual infectious diseases
- Newer antimicrobials and treatment strategies for highly resistant infections
- Prevention and treatment of infections in immunocompromised hosts
- Update on antifungal diagnostics and therapy
- State-of-the-art and multidisciplinary approaches to common infections
- Clinical approaches to complex, rare, and "don't-miss" infections
- New, evolving, emerging, and re-emerging infectious diseases
- Infections in persons with substance use disorder
- What’s new in HIV prevention and management
- The latest on COVID-19, including long COVID
- Adult vaccinations in 2026
As revised treatment strategies, new diagnostic tests, and guidelines are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.
In addition to being live streamed, all sessions will be recorded and placed in the online course library, enabling registrants to view them at their convenience. Recordings will be available for viewing for 90 days after the conclusion of the course. All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 30 days in order to receive CME credit.)
Highlights of the 2026 Program
Expanded Case-Based and Problem-Solving Education
The 2026 program features an expanded range of interactive, case-based, and problem-solving education. The formats are engaging, and attendees are encouraged to pose questions to our national experts in live question-and-answer sessions following the lectures and the multidisciplinary workshops.
Our speakers and panelists include not only ID experts, but those from fields such as pharmacy, surgery, radiology, cardiology, pulmonology, and addiction medicine, thereby providing a 360-degree context for the understanding of ID treatment and patient care.
Our ten multidisciplinary workshops include complicated urinary tract and intra-abdominal infections, resistant Gram-positive and Gram-negative infections, management of endocarditis and cardiac device infections, musculoskeletal infections, and nontuberculous mycobacterial infections.
Treating Highly Resistant Infections, including:
- MRSA and VISA (vancomycin-intermediate Staph aureus)
- Extended-spectrum beta-lactamase (ESBL)-producing Gram-negative rods
- Carbapenemase-producing Gram-negative rods, including NDM-1 metallo-beta-lactamase-producing organisms
- Vancomycin-resistant enterococci (VRE)
- Resistant fungal infections, including Aspergillus, other molds, and resistant Candidal infections
- Nontuberculous mycobacteria (NTM)
Common Infectious Diseases: Updates in Prevention, Diagnosis, and Treatment, including:
- Respiratory viral infections, including COVID-19
- New and updated vaccine guidance
- Infections in the expanding populations of immunocompromised hosts
- Infections in persons with substance use disorder
- Infections of travelers and foreign-born persons
- Systemic fungal infections
- Native and device-related orthopedic infections
- Central nervous system (CNS) infections
- Native and prosthetic valve endocarditis, and cardiac device infections
- Ear, nose, and throat (ENT) and eye infections
- Skin and soft tissue infections
- Bronchiectasis and pneumonia
- HIV and its infectious and noninfectious complications
- PEP (Post-Exposure Prophylaxis) and PrEP (Pre-Exposure Prophylaxis) to prevent HIV infection
- Sexually transmitted infections (STIs), including mpox and PEP for prevention of STIs
- Hepatitis B and C infections
- Tick- and mosquito-borne infections
- Clostridioides difficile infection, the gut microbiome, and pre- and probiotics
- Complicated urinary tract infections
- Intra-abdominal infections
Challenging, Rare, and Emerging Infectious Diseases, including:
- Highly pathogenic avian flu
- Re-emergence of vaccine-preventable diseases, including poliomyelitis
- Pulmonary and extrapulmonary non-tuberculous (“atypical”) mycobacteria, including Mycobacterium abscessus
- Global infectious diseases of clinical importance
Clinical Decision-Making
Hear directly from world-renowned specialists and master clinicians on their approach and decision-making criteria for:
- Selecting the best antimicrobial and duration of treatment
- Rapid detection and empiric treatment of life-threatening infectious diseases
- Choosing between inpatient and outpatient treatment, and between intravenous and oral antimicrobials
- Optimizing empiric antimicrobial therapy: what to start, and how and when to deescalate
Our multidisciplinary talks and workshops incorporate safety, quality, and practice improvement in infectious diseases, including:
- Antimicrobial stewardship to prevent resistance and reduce cost
- Early inpatient ID consultations to improve outcomes
- Strategies for management of infection in persons who inject drugs (PWID)
New in 2026: Advanced Learning Modules
- HIV
- Mycobacterial Infections
Each of these expanded learning modules provides the opportunity to discuss your cases during optional Meet-the-Professors sessions with clinical leaders in these specialized ID fields. We also provide two hours of self-paced, advanced instruction covering in-depth topics in HIV as well as multidisciplinary panel workshops in management of pulmonary and extrapulmonary NTM infections.
Developed and Offered By:
Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Massachusetts General Hospital.
Who Should Participate
Physicians, Nurse Practitioners, Physician Assistants, and Pharmacists in the fields of:
- Infectious Diseases
- Hospital Medicine
- Internal Medicine
- Family Practice
- Pulmonary and Critical Care Medicine
- Emergency Medicine
...and others who care for patients with infectious diseases
NEW in 2026: ADVANCED LEARNING MODULES:
- HIV
- Mycobacterial Infections
Each of these expanded learning modules provides the opportunity to discuss your cases during optional Meet-the-Professors sessions with clinical leaders in these specialized ID fields. We also provide two hours of self-paced, advanced instruction covering in-depth topics in HIV as well as multidisciplinary panel workshops in management of pulmonary and extrapulmonary NTM infections.
PLENARY and KEYNOTE SESSIONS
Two special sessions explore the future of public health and responses to infectious diseases outbreaks. Please join for these discussions of how global changes are likely to affect local responses and your future clinical practice.
- Monday, May 4 at 10:00 am US ET – Keynote Address: The Future of Global Public Health: Lessons from HIV with Dr. Linda-Gail Bekker. Dr. Bekker is the Chief Executive Officer of the Desmond Tutu Health Foundation and the Director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine at the University of Cape Town, South Africa.
- Thursday, May 7 at 4:00 pm US ET – Plenary Session: Preparing for Future Pandemics with Dr. David Oshinsky. Dr. Oshinsky is the Director of the Division of Medical Humanities at NYU Grossman School of Medicine and a Professor in the NYU Department of History.
LIVE NEW ENGLAND JOURNAL of MEDICINE CLINICOPATHOLOGIC CONFERENCE (CPC)
Hone your diagnostic reasoning skills by joining this discussion by expert clinicians of a challenging infectious diseases case. The case presentation and discussion will be published in the future in the New England Journal of Medicine.
Schedule
This program is among the highest-rated Harvard Medical School CME courses.
All agenda sessions are in Eastern Time.
Please note that program changes/substitutions may be made without notice.
Monday, May 4, 2026
Session 1: Monday Morning
Introduction and Road Map: Infectious Diseases of Adults
Dr. Nesli Basgoz
8:00-8:15 am
Advancing Patient Care Through Antimicrobial Stewardship
Dr. Alyssa Letourneau
8:15-9:00 am
Update on Antifungal Diagnostics and Therapy
Dr. Michael Mansour
9:00-9:45 am
Break
9:45-10:00 am
Plenary: The Future of Global Public Health: Lessons from HIV
Dr. Linda-Gail Bekker
10:00-10:40 am
Live Q&A
Dr. Linda-Gail Bekker
10:40-11:00 am
Break
11:00-11:10 am
Eye and ENT Infections: What You Need to Know in 2026
Dr. Miriam Barshak
11:10 am-12:00 pm
Live Q&A
Drs. Miriam Barshak, Nesli Basgoz, Alyssa Letourneau, and Michael Mansour
12:00-12:30 pm
Break
12:30-1:30 pm
Session 2: Monday Afternoon
Multidisciplinary Panel Workshop #1: Resistant Gram-Positive Infections
Drs. Alyssa Letourneau, Roby Bhattacharyya, and Cecilia Li
1:30-2:10 pm
Multidisciplinary Panel Workshop #2: Resistant Gram-Negative Infections
Drs. Alyssa Letourneau, Roby Bhattacharyya, and Cecilia Li
2:10-2:50 pm
Live Q&A
Drs. Alyssa Letourneau, Roby Bhattacharyya, and Cecilia Li
2:50-3:20 pm
Break
3:20-3:30 pm
C. difficile Update, the Gut Microbiome, and Pre- and Probiotics
Dr. Elizabeth Hohmann
3:30-4:15 pm
Skin and Soft Tissue Infections: Current Best Practices for Clinicians
Dr. Sandra Nelson
4:15-4:45 pm
Live Q&A
Drs. Sandra Nelson and Elizabeth Hohmann
4:45-5:05 pm
Tuesday, May 5, 2026
Session 3: Tuesday Morning
Infections Related to Solid Organ Transplant and Non-Oncologic Immunomodulatory Therapy
Dr. Camille Kotton
8:00-8:50 am
Infections in Hematologic Malignancies and Stem Cell Transplantation
Dr. Sarah Hammond
8:50-9:50 am
Break
Flummoxing Cases in Fungal Infections
Drs. Michael Mansour and Sarah Turbett
10:00-10:45 am
Live Q&A
Drs. Camille Kotton, Michael Mansour, Sarah Hammond, and Sarah Turbett
10:45-11:15 am
State-of-the-Art Diagnosis and Management of Sexually Transmitted Infections
Dr. Kevin Ard
11:15 am-12:00 pm
Break
12:00-1:00 pm
Session 4: Tuesday Afternoon
Updates on COVID-19, Including Long COVID
Dr. Rajesh Gandhi
1:00-1:45 pm
Navigating New Vaccines: Updates and Recommendations
Dr. Camille Kotton
1:45-2:15 pm
Advanced Learning Module: HIV
Pre- and Post-Exposure Prophylaxis for HIV and STIs
Dr. Kevin Ard
2:15-2:55 pm
Break
2:55-3:05 pm
What's New in the Care of People with HIV in 2026
Dr. Rajesh Gandhi
3:05-3:50 pm
Addressing the Continuing Challenges in HIV-Associated Opportunistic Infections
Dr. Nesli Basgoz
3:50-4:35 pm
Live Q&A
Drs. Rajesh Gandhi, Nesli Basgoz, Kevin Ard, and Camille Kotton
4:35-5:05 pm
Break
5:05-5:10 pm
Meet-the-Professors Case Discussion Session: HIV
(Repeat session offered on Wednesday morning--please choose only one)
5:10-6:05 pm
Self-Paced Study: HIV
6:05 pm
Prerecorded lectures
Perinatal HIV Infection
Dr. Andrea L. Ciaranello
Metabolic Complications of HIV
Dr. Virginia Triant
CROI Updates
Dr. Rajesh Gandhi
HIV Resistance
Dr. Suzanne McCluskey
Wednesday, May 6, 2026
Meet-the-Professors Case Discussion Session: HIV
(Repeat session offered on Tuesday evening--please choose only one)
7:00-7:55 am
Break
7:55-8:00 am
Session 5: Wednesday Morning
Introduction to TB, Latent TB Infection, and Drug-Susceptible TB
Dr. Jodian Pinkney
8:00-8:30 am
Drug-Resistant TB and TB in Special Populations
Dr. Rocio Hurtado
8:30-9:10 am
Live Q&A
Drs. Rocio Hurtado and Jodian Pinkney
9:10-9:25 am
Break
9:25-9:35 am
Bronchiectasis and NTM Infections: Anatomic and Clinical Approaches
Dr. Nesli Basgoz
9:35-10:20 am
The Latest on Major Respiratory Viral Infections
Dr. Michael Ison
10:20-10:50 am
Innovations in HBV and HCV Care: Updates for 2026
Dr. Arthur Kim
10:50-11:40 am
Live Q&A
Drs. Nesli Basgoz, Rocio Hurtado, and Michael Ison
11:40 am-12:00 pm
Break
12:00-1:00 pm
Session 6: Wednesday Afternoon
Live: New England Journal of Medicine Clinicopathologic Conference (CPC)
1:00-2:00 pm
Clinical Challenges in Tropical Medicine: A 2026 Review
Dr. Edward T. Ryan
2:00-2:35 pm
Global Infectious Diseases: Case-Based Updates
Dr. Edward T. Ryan
2:35-3:15 pm
Live Q&A
Dr. Edward T. Ryan
3:15-3:30 pm
Break
3:30-3:40 pm
Advanced Learning Module: Mycobacterial Infections
Multidisciplinary Panel Workshop #3: Management of Complex Nontuberculous Mycobacterial Infection (NTM): Pulmonary
Dr. Rocio Hurtado and panelists
3:40-4:20 pm
Multidisciplinary Panel Workshop #4: Management of Complex Nontuberculous Mycobacterial Infection (NTM): Extrapulmonary
Dr. Rocio Hurtado and panelists
4:20-5:00 pm
Live Q&A
Dr. Rocio Hurtado and panelists
5:00-5:30 pm
Break
5:30-5:35 pm
Meet-the-Professors Case Discussion Session: Mycobacterial Infections
(Repeat session offered on Thursday morning--please choose only one)
5:35-6:30 pm
Thursday, May 7, 2026
Meet-the-Professors Case Discussion Session: Mycobacterial Infections
(Repeat session offered on Wednesday evening--please choose only one)
7:00-7:55 am
Break
7:55-8:00 am
Session 7: Thursday Morning
Encephalitis and Meningitis: Guidelines and Best Practices
Dr. Allan Tunkel
8:00-9:00 am
Tick Talk: Lyme Disease, Ehrlichia, Anaplasma, Babesia, and Rickettsia
Dr. Kimon Zachary
9:00-9:50 am
Live Q&A
Drs. Allan Tunkel and Kimon Zachary
9:50-10:05 am
Break
10:05-10:15 am
Bone and Joint infections: A Conceptual Framework
Dr. Sandra Nelson
10:15-11:05 am
Staphylococcus aureus: Déjà Vu All Over Again
Dr. Henry Chambers
11:05-11:55 am
Live Q&A
Drs. Sandra Nelson and Henry Chambers
11:55 am-12:10 pm
Break
12:10-1:10 pm
Session 8: Thursday Afternoon
Multidisciplinary Panel Workshop #5: Native Bone Infections
Dr. Sandra Nelson and panelists
1:10-1:50 pm
Multidisciplinary Panel Workshop #6: Orthopedic Device Infections: Prosthetic Joint Infections
Dr. Sandra Nelson and panelists
1:50-2:30 pm
Live Q&A
Dr. Sandra Nelson and panelists
2:30-3:00 pm
Break
3:00-3:10 pm
New and Emerging Viruses: Clinical Insights for Frontline Providers and ID Specialists
Dr. Martin Hirsch
3:10-4:00 pm
KEYNOTE: Preparing for Future Pandemics
Dr. David Oshinsky
4:00-4:40 pm
Live Q&A
Drs. Martin Hirsch and David Oshinsky
4:40-5:10 pm
Friday, May 8, 2026
Session 9: Friday Morning
Intra-abdominal Infections: A Conceptual Framework
Dr. Nesli Basgoz
8:00-8:35 am
Urinary Tract Infections: A Conceptual Framework
Dr. Jacob Lazarus
8:35-9:10 am
Critical Care ID and Sepsis for the ID Clinician
Dr. Lisa Bebell
9:10-9:50 am
Live Q&A
Drs. Nesli Basgoz, Jacob Lazarus, and Lisa Bebell
9:50-10:20 am
Break
10:20-10:30 am
Multidisciplinary Workshop #7: Management of Complex Intra-abdominal Infections
Dr. Nesli Basgoz and panelists
10:30-11:10 am
Multidisciplinary Workshop #8: Management of Complex Urinary Tract Infections
Dr. Jacob Lazarus and panelists
11:10-11:50 am
Live Q&A
Drs. Nesli Basgoz, Jacob Lazarus, and panelists
11:50 am-12:20 pm
Break
12:20-1:20 pm
Endocarditis and Cardiac Device Infections
Dr. Molly Paras
1:20-2:15 pm
The Syndemic of SUD and Infection: Updated Approaches for 2026
Dr. Jennifer Johnson
2:15-3:00 pm
Live Q&A
Drs. Molly Paras and Jennifer Johnson
3:00-3:20 pm
Break
3:20-3:30 pm
Multidisciplinary Workshop #9: Management of Endocarditis
Dr. Molly Paras and panelists
3:30-4:10 pm
Multidisciplinary Workshop #10: Management of Cardiac Device Infections
Dr. Molly Paras and panelists
4:10-4:50 pm
Live Q&A
Dr. Molly Paras and panelists
4:50-5:20 pm
New for 2026: Meet-the-Professors Case Discussion Sessions
As part of the Advanced Learning Modules in HIV and Mycobacterial Infections, you can discuss one of your cases with clinical leaders in these specialized ID fields during a Meet-the-Professors session. The opportunity to present cases will be limited to the first 20 attendees who submit a case, but all are welcome to attend and listen to the discussion.
For your convenience, Meet-the-Professors case discussion sessions are offered twice on each topic, once in the early morning and once in the late afternoon/evening. If you would like to attend a Meet-the-Professors session on either HIV or Mycobacterial Infections, we ask that you choose only one session on each topic and let us know of your choice when you register for the course.
HIV Meet-the-Professors sessions
» Tuesday, May 5, 2026, 5:10–6:05 pm
Or
» Wednesday, May 6, 2026, 7:00–7:55 am
Mycobacterial Infections Meet-the-Professors sessions
» Wednesday, May 6, 2026, 5:35–6:30 pm
Or
» Thursday, May 7, 2026, 7:00–7:55 am
Optimized for Distance Learning
The 2026 program has been optimized for distance learning.
In addition to being live streamed, all sessions and Q & A discussions will be recorded and made available to participants for online viewing for 90 days after the end of the course. This on-demand archive will permit those in different time zones or who have scheduling conflicts to avoid missing out on any sessions that are important to them. In addition, participants can review sessions to reinforce key learning points.
All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 30 days in order to receive CME credit.)
Learning Objectives
Upon completion of this course, participants will be able to:
- Utilize the latest strategies for the prevention, diagnosis, and management of important infectious disease syndromes in immunocompetent and immunocompromised patients
- Describe updated guidelines on the treatment of infectious diseases
- Summarize principles of judicious antimicrobial selection, dose, route, and duration to optimize patient outcomes while preventing resistance and lowering cost
- Describe evidence-based treatments as well as new treatment paradigms for resistant organisms and difficult-to-treat infections
- Recognize the role of novel, rapid diagnostics of infection and resistance in infectious disease practice
- Recognize the epidemiologic risk factors for emerging infectious diseases and provide optimal empiric and target therapies for infections
- Design and implement multidisciplinary care for patients in areas such as hematology oncology, solid organ transplantation, musculoskeletal infections, endocarditis, abdominal infections, and genitourinary infections
Faculty
Course Director
Nesli Basgoz
MD
- MGH Master Clinician Endowed Chair in Infectious Diseases
- Chief, Jackson Firm, Department of Medicine, Massachusetts General Hospital
- Associate Professor of Medicine, Harvard Medical School
Course Co-Directors
Ruanne V. Barnabas
MBChB, MSc, DPhil, FIDSA
- Chief, Division of Infectious Diseases
- MGH Francis and Dorothea Reed Endowed Chair in Infectious Diseases, Massachusetts General Hospital
- Professor of Medicine, Harvard Medical School
- Professor of Epidemiology, Harvard T.H. Chan School of Public Health
Rajesh T. Gandhi
MD
- Director, HIV Education, Division of Infectious Diseases, Massachusetts General Hospital
- Vice Chair, ACTG
- Co-Director, Harvard University Center for AIDS Research
- Professor of Medicine, Harvard Medical School
Sandra B. Nelson
MD
- Co-Clinical Director, Division of Infectious Diseases
- Director, Musculoskeletal Infectious Disease and Outpatient Parenteral Antibiotic Therapy Programs
- Division of Infectious Diseases, Massachusetts General Hospital
- Associate Professor of Medicine, Harvard Medical School
Kevin L. Ard, MD, MPH, Assistant Professor of Medicine, Harvard Medical School; Physician, Division of Infectious Diseases, Massachusetts General Hospital
Miriam B. Barshak, MD, Associate Professor of Medicine, Harvard Medical School; Distinguished Physician, Division of Infectious Diseases, Massachusetts General Hospital; Clinical Associate in Infectious Diseases, Massachusetts Eye and Ear Infirmary
Nesli Basgoz, MD, Associate Professor of Medicine, Harvard Medical School; MGH Master Clinician Endowed Chair in Infectious Diseases and Chief, Jackson Firm, Department of Medicine, Massachusetts General Hospital
Lisa Bebell, MD, MSc, Assistant Professor of Medicine, Harvard Medical School; Physician, Division of Infectious Diseases, Massachusetts General Hospital
Roby P. Bhattacharyya, MD, PhD, Assistant Professor of Medicine, Harvard Medical School; Physician, Massachusetts General Hospital
Andrea L. Ciaranello, MD, Professor of Medicine, Harvard Medical School; Physician, Division of Infectious Diseases, Massachusetts General Hospital
Benjamin T. Davis, MD, Assistant Professor of Medicine, Harvard Medical School; Distinguished Physician, Division of Infectious Diseases, Massachusetts General Hospital
Rajesh T. Gandhi, MD, Professor of Medicine, Harvard Medical School; ACTG Vice Chair and Site Leader; Director, HIV Education, Division of Infectious Diseases, Massachusetts General Hospital; Co-Director, Harvard University Center for AIDS Research
Sarah P. Hammond, MD, Assistant Professor of Medicine, Harvard Medical School; Physician, Divisions of Infectious Diseases and Hematology/Oncology, Department of Medicine, Massachusetts General Hospital
Martin S. Hirsch, MD, Emeritus Professor of Medicine, Harvard Medical School; Honorary Physician, Division of Infectious Diseases, Massachusetts General Hospital
Elizabeth L. Hohmann, MD, Associate Professor of Medicine, Harvard Medical School; Distinguished Physician, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital
Rocío M. Hurtado, MD, DTM&H, Assistant Professor of Medicine, Harvard Medical School; Director, Mycobacterial Center, Infectious Disease Unit, Massachusetts General Hospital
Kristen M. Hysell, MD, MPH, Instructor in Medicine, Harvard Medical School; Associate Physician, Division of Infectious Diseases, Massachusetts General Hospital
Arminder S. Jassar, MBBS, Assistant Professor of Surgery, Harvard Medical School; Co-Director, Massachusetts General Hospital Thoracic Aortic Center
Jennifer A. Johnson, MD, Assistant Professor of Medicine, Harvard Medical School; Associate Physician, Division of Infectious Diseases, Brigham and Women's Hospital
Arthur Y. Kim, MD, Associate Professor of Medicine, Harvard Medical School; Director, Viral Hepatitis Clinic, Division of Infectious Diseases, Massachusetts General Hospital
Camille Nelson Kotton, MD, Associate Professor of Medicine, Harvard Medical School; Clinical Director, Transplant and Immunocompromised Host, Infectious Diseases, Massachusetts General Hospital
Michael Lanuti, MD, Associate Professor of Surgery, Harvard Medical School; Director, Thoracic Oncology, Division of Thoracic Surgery, Massachusetts General Hospital
Jacob E. Lazarus, MD, PhD, Assistant Professor of Medicine, Harvard Medical School; Associate Physician, Division of Infectious Diseases, Massachusetts General Hospital
Alyssa R. Letourneau, MD, MPH, Assistant Professor of Medicine, Harvard Medical School; Director, Antimicrobial Stewardship Program; Physician, Division of Infectious Diseases, Massachusetts General Hospital
Michael K. Mansour, MD, PhD, Associate Professor of Medicine, Harvard Medical School; Associate Physician, Division of Infectious Diseases, Massachusetts General Hospital
Suzanne M. McCluskey, MD, Assistant Professor of Medicine, Harvard Medical School; Associate Physician, Division of Infectious Diseases, Massachusetts General Hospital
Ruvandhi Nathavitharana, MD, MPH, Assistant Professor of Medicine, Harvard Medical School; Infectious Diseases Physician, Beth Israel Deaconess Medical Center
Sandra B. Nelson, MD, Associate Professor of Medicine, Harvard Medical School; Co-Clinical Director, Division of Infectious Diseases, and Director, Musculoskeletal Infectious Disease and Outpatient Parenteral Antibiotic Therapy Programs, Division of Infectious Diseases, Massachusetts General Hospital
Molly L. Paras, MD, Assistant Professor of Medicine, Harvard Medical School; Physician, Division of Infectious Diseases, Massachusetts General Hospital
Jodian A. Pinkney, MD, Instructor in Medicine, Harvard Medical School; Associate Physician, Division of Infectious Diseases, Massachusetts General Hospital
Christopher J. Richards, MD, Instructor in Medicine, Harvard Medical School; Cystic Fibrosis Pulmonologist, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital
Eric S. Rosenberg, MD, Professor of Pathology, Harvard Medical School; Physician in Medicine, and Director, Clinical Microbiology Laboratory, Massachusetts General Hospital
Edward T. Ryan, MD, Professor of Medicine, Harvard Medical School; Distinguished Physician and Director, Global Infectious Diseases, Massachusetts General Hospital
Virginia A. Triant, MD, Assistant Professor of Medicine, Harvard Medical School; Associate Physician, Division of Infectious Diseases, Massachusetts General Hospital
Sarah E. Turbett, MD, Assistant Professor of Medicine, Harvard Medical School; Assistant Director, Clinical Microbiology Laboratories and Assistant in Medicine, Division of Infectious Diseases, Massachusetts General Hospital
Evin Yucel, MD, Assistant Professor of Medicine, Harvard Medical School; Cardiologist, Division of Cardiology, Massachusetts General Hospital
Kimon C. Zachary, MD, Assistant Professor of Medicine, Harvard Medical School; Distinguished Physician, Division of Infectious Diseases, Massachusetts General Hospital
Linda-Gail Bekker, MBChB, PhD, Chief Executive Officer, Desmond Tutu Health Foundation; Director, Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine at the University of Cape Town, South Africa
Henry F. Chambers, MD, Professor of Medicine, University of California at San Francisco School of Medicine; Director, Clinical Research Services, UCSF Clinical and Translational Sciences Institute; Chief, Division of Infectious Diseases, San Francisco General Hospital
Michael G. Ison, MD, MS, Chief, Respiratory Diseases Branch, Division of Microbiology and Infectious Diseases, NIAID/NIH
Cecilia Li, PharmD, BCIDP, Infectious Diseases Clinical Pharmacist, Massachusetts General Hospital
David Oshinsky, PhD, Director, Division of Medical Humanities at NYU Grossman School of Medicine; Professor, NYU Department of History
Alex E. Rock, PharmD, AAHIVP, BCPS, BCIDP, Infectious Diseases Clinical Pharmacist, Massachusetts General Hospital
Allan R. Tunkel, MD, PhD, MACP, Professor of Medicine, Chief of Medical Education, Professor of Medical Science, The Warren Alpert Medical School of Brown University
Course Fees
Registration Details
Registrations for Harvard Medical School CME programs are made via our secure online registration system. At the end of the registration process, a $10 non-refundable processing fee will be added to your registration.
Upon receipt of your paid registration, an email confirmation will be sent to you. Be sure to include an email address that you check frequently. Your email address is used for critical information, including registration confirmation, evaluation, and certificate.
Please review the cancellation policy.
Early Registration Deadline:
| Role | Course Fee | Early Registration Course Fee |
|---|---|---|
| Physician (MD/DO) | $1,375.00 | $1,275.00 |
| Nurse (RN/APRN) | $1,375.00 | $1,275.00 |
| PA | $1,375.00 | $1,275.00 |
| Resident/Fellow | $995.00 | $895.00 |
| Allied Health Professional / Other | $1,375.00 | $1,275.00 |
All registrants of Infectious Diseases in Adults 2026 will receive an electronic syllabus.
All sessions will be recorded as they are live streamed and placed in the online course video library, so that registrants can review them at their convenience. The video library will be available for 90 days after the conclusion of the course.
Accreditation
The Harvard Medical School designates this live activity for a maximum of 45.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Harvard Medical School designates this knowledge-based activity for a maximum of 45.25 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN JA0000216-0000-26-001-L01-P.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 45.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
The AAFP has reviewed Infectious Diseases in Adults 2026 and deemed it acceptable for up to 45.25 Live AAFP Prescribed credit(s). Term of Approval is from 05/04/2026 to 05/08/2026. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 9.25 credits of Risk Management Study. This includes:
- 6.25 credits of Opioid Education and Pain Management Training.
Please check your individual state licensing board requirements before claiming these credits.
For the purpose of recertification, the American Academy of Nurse Practitioners Certification Board and American Nurses Credentialing Center accept AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education). We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.
The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found on the European Union of Medical Specialties website.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.